Romiplostim for Treatment of Children and Young Adults With Severe Aplastic Anemia and Myelodysplastic Syndrome.

MLA

Sharathkumar, Anjali, et al. “Romiplostim for Treatment of Children and Young Adults With Severe Aplastic Anemia and Myelodysplastic Syndrome.” Journal of Pediatric Hematology/Oncology, vol. 46, no. 5, July 2024, pp. 252–61. EBSCOhost, https://doi.org/10.1097/MPH.0000000000002891.

APA

Sharathkumar, A., Carr, J., Claassen, D., Syrbu, S., Bhagavathi, S., Al-Huniti, A., Modi, A., Bates, M., & Mott, S. L. (2024). Romiplostim for Treatment of Children and Young Adults With Severe Aplastic Anemia and Myelodysplastic Syndrome. Journal of Pediatric Hematology/Oncology, 46(5), 252–261. https://doi.org/10.1097/MPH.0000000000002891

Chicago

Sharathkumar, Anjali, Jamie Carr, David Claassen, Sergei Syrbu, Sharathkumar Bhagavathi, Ahmad Al-Huniti, Arunkumar Modi, Melissa Bates, and Sarah L Mott. 2024. “Romiplostim for Treatment of Children and Young Adults With Severe Aplastic Anemia and Myelodysplastic Syndrome.” Journal of Pediatric Hematology/Oncology 46 (5): 252–61. doi:10.1097/MPH.0000000000002891.